The Long Run with Luke Timmerman
A podcast by Timmerman Report
173 Episoade
-
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
Publicat: 16.03.2025 -
Ep174: Najat Khan on the TechBio Movement
Publicat: 03.03.2025 -
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders
Publicat: 11.02.2025 -
Ep172: Mostafa Ronaghi on Studying Live Cells at Scale
Publicat: 27.01.2025 -
Ep171: Ram Aiyar on RNA Editing Medicines
Publicat: 13.01.2025 -
Ep170: David Schenkein on Investing in the Future of Biotech
Publicat: 02.01.2025 -
Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines
Publicat: 11.12.2024 -
Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer
Publicat: 25.11.2024 -
Ep167: Leslie Williams on transfer RNA therapies
Publicat: 06.11.2024 -
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
Publicat: 15.10.2024 -
Ep165: Zach Hornby on Tackling Cancer Drug Resistance
Publicat: 26.09.2024 -
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
Publicat: 05.09.2024 -
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
Publicat: 14.08.2024 -
Ep162: Sean McClain on AI for Biologic Drug Discovery
Publicat: 16.07.2024 -
Ep161: Jeff Stein on a Long-Lasting Flu Drug
Publicat: 01.07.2024 -
Ep160: Abe Ceesay on Precision Neuroscience
Publicat: 17.06.2024 -
Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease
Publicat: 03.06.2024 -
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
Publicat: 20.05.2024 -
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
Publicat: 01.05.2024 -
Ep156: David Liu on New Tools and Techniques for Biology
Publicat: 16.04.2024
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
